Ochre Bio Revenue and Competitors

Oxford,

Location

#5106

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Ochre Bio's estimated annual revenue is currently $10.1M per year.(i)
  • Ochre Bio's estimated revenue per employee is $155,000

Employee Data

  • Ochre Bio has 65 Employees.(i)
  • Ochre Bio grew their employee count by 3% last year.

Ochre Bio's People

NameTitleEmail/Phone
1
CSO, Co-founderReveal Email/Phone
2
Head Research, OxfordReveal Email/Phone
3
VP Translational DevelopmentReveal Email/Phone
4
Associate DirectorReveal Email/Phone
5
Director, In Silico BiologyReveal Email/Phone
6
Director, Programme ManagementReveal Email/Phone
7
Director, Preclinical DevelopmentReveal Email/Phone
8
Director, Corporate Strategy and Business DevelopmentReveal Email/Phone
9
Associate DirectorReveal Email/Phone
10
Clinical Research LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Ochre Bio?

Many donor livers are too unhealthy or damaged to be transplanted and so go to waste, even though one in six patients die waiting for a new liver. The main reason for discarding a donor liver is that it contains too much fat. At Ochre we develop genomic medicines that rejuvenate transplanted livers, ultimately with the goal of applying these therapies to treat fatty liver disease (NASH/NAFL) and other cardiometabolic diseases. We employ spatial sequencing, advanced genomics, and high-throughput screening to identify disease-causing genes, and develop combination therapies which are tested in donor livers kept alive outside of the body. Our scientific roots can be traced back over 15 years leading liver genomics research, and experience in bringing advanced therapies to market. Privately held, Ochre Bio is situated within the heart of Oxford's biotech innovation hub. To learn more, please visit www.ochre-bio.com.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$10.1M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ochre Bio News

2022-04-13 - LifeShare celebrates Donate Life Month | Community

LifeShare Oklahoma partners with OrganOx and Ochre Bio to study perfusion ... LifeShare of Oklahoma has recently partnered with Ochre Bio,...

2022-04-06 - Chirps, chats and Clubhouses: First-time biotech founders turn to ...

But finding financing for Ochre Bio was a little tougher than he ... with fellow first-time founder Nabiha Saklayen, CEO of Cellino Bio.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.3M655%N/A
#2
$13.3M67-12%N/A
#3
$8.4M672%N/A
#4
$8.7M6768%N/A
#5
$15M6819%N/A